Plenary session 2

  • Location:
    Lindenbergzaal
  • Chairs:
     R.M. Adam, Boston (US)
     H.Y. Leung, Glasgow (GB)
Tumor heterogeneity and personalized genomic biomarkers in bladder cancer
 L. Dyrskjøt, Aarhus N (DK)
Prodrug: From concept to clinical trial
 J. Isaacs, Baltimore (US)